Cargando…

Veno-Arterial Extracorporeal Membrane Oxygenation in Elective High-Risk Percutaneous Coronary Interventions

BACKGROUND: The safety and feasibility of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as mechanical circulatory support in high-risk percutaneous coronary intervention (HR-PCI) remain unclear. METHODS: This retrospective study included patients with complex and high-risk coronary art...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Ming, Lu, Andong, Pan, Chenliang, Hu, Sixiong, Qu, Wenjing, Zhao, Jing, Zhang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178105/
https://www.ncbi.nlm.nih.gov/pubmed/35692539
http://dx.doi.org/10.3389/fmed.2022.913403
_version_ 1784722983387922432
author Bai, Ming
Lu, Andong
Pan, Chenliang
Hu, Sixiong
Qu, Wenjing
Zhao, Jing
Zhang, Bo
author_facet Bai, Ming
Lu, Andong
Pan, Chenliang
Hu, Sixiong
Qu, Wenjing
Zhao, Jing
Zhang, Bo
author_sort Bai, Ming
collection PubMed
description BACKGROUND: The safety and feasibility of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as mechanical circulatory support in high-risk percutaneous coronary intervention (HR-PCI) remain unclear. METHODS: This retrospective study included patients with complex and high-risk coronary artery disease who underwent elective PCI with VA-ECMO support pre-operatively during March 2019–December 2020. Rates of VA-ECMO-related complications, complications during PCI, death, myocardial infarction, and stroke during hospitalisation and 1-year post-operatively were analysed. RESULTS: Overall, 36 patients (average age: 63.6 ± 8.9 years) underwent PCI. The average duration of VA-ECMO support was 12.5 (range, 3.0–26.3) h. Intra-aortic balloon pump counterpulsation was used in 44.4% of patients. The SYNTAX score was 34.6 ± 8.4 pre-operatively and 10.8 ± 8.8 post-operatively (P < 0.001). Intraoperative complications included pericardial tamponade (N = 2, 5.6%), acute left-sided heart failure (N = 1, 2.8%), malignant arrhythmia requiring electrocardioversion (N = 2, 5.6%), and no deaths. Blood haemoglobin levels before PCI and 24 h after VA-ECMO withdrawal were 145.4 ± 20.2 g/L and 105.7 ± 21.7 g/L, respectively (P < 0.001). Outcomes during hospitalisation included death (N = 1, 2.8%), stroke (N = 1, 2.8%), lower limb ischaemia (N = 2, 5.6%), lower limb deep venous thrombosis (N = 1, 2.8%), cannulation site haematoma (N = 2, 5.6%), acute renal injury (N = 2, 5.6%), bacteraemia (N = 2, 5.6%), bleeding requiring blood transfusion (N = 5, 13.9%), and no recurrent myocardial infarctions. Within 1 year post-operatively, two patients (5.6%) were hospitalised for heart failure. CONCLUSIONS: Veno-arterial extracorporeal membrane oxygenation mechanical circulation support during HR-PCI is a safe and feasible strategy for achieving revascularisation in complex and high-risk coronary artery lesions. VA-ECMO-related complications require special attention.
format Online
Article
Text
id pubmed-9178105
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91781052022-06-10 Veno-Arterial Extracorporeal Membrane Oxygenation in Elective High-Risk Percutaneous Coronary Interventions Bai, Ming Lu, Andong Pan, Chenliang Hu, Sixiong Qu, Wenjing Zhao, Jing Zhang, Bo Front Med (Lausanne) Medicine BACKGROUND: The safety and feasibility of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as mechanical circulatory support in high-risk percutaneous coronary intervention (HR-PCI) remain unclear. METHODS: This retrospective study included patients with complex and high-risk coronary artery disease who underwent elective PCI with VA-ECMO support pre-operatively during March 2019–December 2020. Rates of VA-ECMO-related complications, complications during PCI, death, myocardial infarction, and stroke during hospitalisation and 1-year post-operatively were analysed. RESULTS: Overall, 36 patients (average age: 63.6 ± 8.9 years) underwent PCI. The average duration of VA-ECMO support was 12.5 (range, 3.0–26.3) h. Intra-aortic balloon pump counterpulsation was used in 44.4% of patients. The SYNTAX score was 34.6 ± 8.4 pre-operatively and 10.8 ± 8.8 post-operatively (P < 0.001). Intraoperative complications included pericardial tamponade (N = 2, 5.6%), acute left-sided heart failure (N = 1, 2.8%), malignant arrhythmia requiring electrocardioversion (N = 2, 5.6%), and no deaths. Blood haemoglobin levels before PCI and 24 h after VA-ECMO withdrawal were 145.4 ± 20.2 g/L and 105.7 ± 21.7 g/L, respectively (P < 0.001). Outcomes during hospitalisation included death (N = 1, 2.8%), stroke (N = 1, 2.8%), lower limb ischaemia (N = 2, 5.6%), lower limb deep venous thrombosis (N = 1, 2.8%), cannulation site haematoma (N = 2, 5.6%), acute renal injury (N = 2, 5.6%), bacteraemia (N = 2, 5.6%), bleeding requiring blood transfusion (N = 5, 13.9%), and no recurrent myocardial infarctions. Within 1 year post-operatively, two patients (5.6%) were hospitalised for heart failure. CONCLUSIONS: Veno-arterial extracorporeal membrane oxygenation mechanical circulation support during HR-PCI is a safe and feasible strategy for achieving revascularisation in complex and high-risk coronary artery lesions. VA-ECMO-related complications require special attention. Frontiers Media S.A. 2022-05-26 /pmc/articles/PMC9178105/ /pubmed/35692539 http://dx.doi.org/10.3389/fmed.2022.913403 Text en Copyright © 2022 Bai, Lu, Pan, Hu, Qu, Zhao and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Bai, Ming
Lu, Andong
Pan, Chenliang
Hu, Sixiong
Qu, Wenjing
Zhao, Jing
Zhang, Bo
Veno-Arterial Extracorporeal Membrane Oxygenation in Elective High-Risk Percutaneous Coronary Interventions
title Veno-Arterial Extracorporeal Membrane Oxygenation in Elective High-Risk Percutaneous Coronary Interventions
title_full Veno-Arterial Extracorporeal Membrane Oxygenation in Elective High-Risk Percutaneous Coronary Interventions
title_fullStr Veno-Arterial Extracorporeal Membrane Oxygenation in Elective High-Risk Percutaneous Coronary Interventions
title_full_unstemmed Veno-Arterial Extracorporeal Membrane Oxygenation in Elective High-Risk Percutaneous Coronary Interventions
title_short Veno-Arterial Extracorporeal Membrane Oxygenation in Elective High-Risk Percutaneous Coronary Interventions
title_sort veno-arterial extracorporeal membrane oxygenation in elective high-risk percutaneous coronary interventions
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178105/
https://www.ncbi.nlm.nih.gov/pubmed/35692539
http://dx.doi.org/10.3389/fmed.2022.913403
work_keys_str_mv AT baiming venoarterialextracorporealmembraneoxygenationinelectivehighriskpercutaneouscoronaryinterventions
AT luandong venoarterialextracorporealmembraneoxygenationinelectivehighriskpercutaneouscoronaryinterventions
AT panchenliang venoarterialextracorporealmembraneoxygenationinelectivehighriskpercutaneouscoronaryinterventions
AT husixiong venoarterialextracorporealmembraneoxygenationinelectivehighriskpercutaneouscoronaryinterventions
AT quwenjing venoarterialextracorporealmembraneoxygenationinelectivehighriskpercutaneouscoronaryinterventions
AT zhaojing venoarterialextracorporealmembraneoxygenationinelectivehighriskpercutaneouscoronaryinterventions
AT zhangbo venoarterialextracorporealmembraneoxygenationinelectivehighriskpercutaneouscoronaryinterventions